Product Code: ANV1844
REPORT HIGHLIGHT
Hemostats market size was valued at USD 2,342.32 Million in 2022, expanding at a CAGR of 7.9% from 2023 to 2030.
Hemostat is known as a surgical agent that is used to control the bleeding process throughout surgical procedures. It help to minimize surgery time and reduce the requirement for blood transfusion. Hemostat agents are crucial in achieving hemostasis in pre-hospital conditions and avoiding death associated with hemorrhage. Additionally, hemostats are utilized to constrict blood vessels and control the flow of fluids including blood. To manage bleeding, they are commonly used as an adjuvant to surgical procedures. Hemostatic agents provide different advantages, such as a reduction in the patient recovery period, minimized wound healing & operative time, and better management of anti-coagulated patients fueling the hemostasis market.
Hemostats Market- Market Dynamics
Rising surgical procedures are propelling the market growth
An increasing number of regulatory approvals, growing focuses on effective blood loss management in patients during surgeries, and an increase in the incidence of sports-related injuries and spinal ailments are raising the number of surgical procedures across the globe, which is expected to drive the hemostats market growth. Moreover, the rise in the geriatric population significantly contributes toward the growth of the market as aged individuals are highly susceptible to several types of diseases, which increases the requirement for surgeries, as a result boosting the hemostats market share. Additionally, the increase in the number of road accidents has been attributed to the surge in surgical procedures, which augmented the hemostats market growth. However, high hemostat product costs and alternative treatment alternatives are expected to restrain the market demand. Furthermore, the market revenue growth is expected to be driven by the growing number of healthcare professionals and awareness about the advantages of utilizing hemostat patients. Various medical specialties such as orthopedics, cardiology, general surgery, and neurology are employing hemostat products extensively thus, fueling the market demand.
Hemostats Market- Key Insights
- As per the analysis shared by our research analyst, the global hemostats market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2023-2030)
- The hemostats industry is projected to grow at a significant rate due to the increasing surgical procedure
- Based on type segmentation, thrombin-based hemostats was predicted to show maximum market share in the year 2022
- Based on application segmentation, orthopedic surgery was the leading type in 2022
- Based on Region, North America was the leading revenue generator in 2022.
Hemostats Market- Segmentation Analysis:
The global hemostats market is segmented on the basis of type, formulation, application, end use, and region.
The market is divided into five categories based on type: collagen-based hemostats, thrombin-based hemostats, gelatin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, and others. The thrombin-based hemostats segment is accounted to dominate the largest revenue share. The segment is attributed to the rise in the adoption of thrombin-based hemostats owing to their quick effect as they quickly facilitate the clotting process. Additionally, an increase in investments in the development of new hemostat products and the benefits associated with the use of combination hemostats, as they provide enhanced efficacy by combining the advantages of various hemostatic agents is expected to witness the segment growth.
The market is divided into six categories based on application: gynecological surgery, orthopedic surgery, general surgery, reconstructive surgery, neurological surgery, cardiovascular surgery, and others. The orthopedic surgery segment is likely to possess the highest market share due to the higher incidence of orthopedic conditions & sports injuries that need surgical interventions, leading to the rising number of procedures thus cumulative the uptake of hemostats. Furthermore, the cardiovascular segment is accounted to witness the highest growth rate owing to the increasing geriatric population, and unhealthy lifestyle leading to an increase in the number of cardiovascular disorders, which, in turn, has led to a rise in the number of cardiac surgeries.
Hemostats Market- Geographical Insights
North America is likely to lead in revenue generation across the globe. The rising number of surgical procedures occurring in the region can be attributed to the increasing patient population requiring surgical procedures, a highly potent market in terms of product development and launches, advanced healthcare infrastructure, and the local presence of various market players among other factors in the region. Moreover, the Asia Pacific market is accounted to have the quickest revenue share. The market demand in the region is anticipated to grow in the region due to the increase in surgical procedures and the increased senior population in developing economies such as India and China.
Hemostats Market- Competitive Landscape:
Governments across the world are investing in healthcare infrastructure to provide improved healthcare services, which has increased the need for hemostat products due to the rising number of clinics, hospitals, and healthcare facilities. Thereby, the rising funding by the federal government to boost the adoption of these solutions further influences the market growth. Moreover, an increase in the number of hospitals & surgical centers and growing R&D activities in the market will provide trending opportunities for the hemostats market. Market players are constantly focusing on adopting strategies to expand their business including product innovation, partnership, mergers and acquisitions, and collaboration. For instance, in July 2021, Rapid-Seal is an efficient, antibacterial hemostatic gel developed by Medcura, Inc. in collaboration with ASO, LLC. Medcura's FDA-approved injuries gel is the first in an emerging category of products that provide antibacterial properties and quick bleeding handling to enhance wound treatment, aid in the fight against infections caused by wounds, and promote a safe healing surroundings.
Recent Developments:
For instance, in July 2023, Baxter International Inc. introduced the launch of PERCLOT Absorbable Hemostatic Powder. PERCLOT is a ready for use apathetic, absorbable hemostatic powder designed for people with intact coagulation to control minor bleeding.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEMOSTATS MARKET KEY PLAYERS
- Marine Polymer Technologies, Inc.
- Gelita Medical GmbH
- Stryker
- Teleflex
- B. Braun Melsungen AG
- Integra LifeSciences
- Anika Therapeutics, Inc.
- Z-Medica LLC
- Ethicon, Inc.
- CR Bard, Inc.
- Life sciences Corporation
- Baxter International, Inc.
GLOBALHEMOSTATS MARKET, BY TYPE
- Collagen Based Hemostats
- Thrombin Based Hemostats
- Gelatin Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Others
GLOBAL HEMOSTATS MARKET, BY FORMULATION
- Powder Hemostats
- Matrix and Gel Hemostats
- Sponge Hemostats
- Sheet and Pad Hemostats
- Others
GLOBAL HEMOSTATS MARKET, BY APPLICATION
- Gynecological Surgery
- Orthopedic Surgery
- General Surgery
- Reconstructive Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Others
GLOBAL HEMOSTATS MARKET, BY END USE
- Ambulatory centers
- Hospitals
- Clinics
- Community healthcare
- Others
GLOBAL HEMOSTATS MARKET, BY REGION
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Hemostats Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Hemostats Market Snippet by Type
- 2.1.2. Hemostats Market Snippet by Formulation
- 2.1.3. Hemostats Market Snippet by Application
- 2.1.4. Hemostats Market Snippet by End Use
- 2.1.5. Hemostats Market Snippet by Country
- 2.1.6. Hemostats Market Snippet by Region
- 2.2. Competitive Insights
3. Hemostats Key Market Trends
- 3.1. Hemostats Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Hemostats Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Hemostats Market Opportunities
- 3.4. Hemostats Market Future Trends
4. HemostatsIndustry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Hemostats Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Hemostats Market Landscape
- 6.1. Hemostats Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Hemostats Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
- 7.1.2. Collagen Based Hemostats
- 7.1.3. Thrombin Based Hemostats
- 7.1.4. Gelatin Based Hemostats
- 7.1.5. Oxidized Regenerated Cellulose Based Hemostats
- 7.1.6. Combination Hemostats
- 7.1.7. Others
8. Hemostats Market - By Formulation
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Formulation, 2022&2030 (%)
- 8.1.2. Powder Hemostats
- 8.1.3. Matrix and Gel Hemostats
- 8.1.4. Sponge Hemostats
- 8.1.5. Sheet and Pad Hemostats
- 8.1.6. Others
9. Hemostats Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
- 9.1.2. Gynecological Surgery
- 9.1.3. Orthopedic Surgery
- 9.1.4. General Surgery
- 9.1.5. Reconstructive Surgery
- 9.1.6. Neurological Surgery
- 9.1.7. Cardiovascular Surgery
- 9.1.8. Others
10. Hemostats Market - By End Use
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End Use, 2022&2030 (%)
- 10.1.2. Ambulatory centers
- 10.1.3. Hospitals
- 10.1.4. Clinics
- 10.1.5. Community healthcare
- 10.1.6. Others
11. Hemostats Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Hemostats Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Hemostats Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Hemostats Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Hemostats Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Hemostats Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Formulation, 2018 - 2030 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Hemostats Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Marine Polymer Technologies, Inc.
- 12.2.2. Gelita Medical GmbH
- 12.2.3. Stryker
- 12.2.4. Teleflex
- 12.2.5. B. Braun Melsungen AG
- 12.2.6. Integra LifeSciences
- 12.2.7. Anika Therapeutics, Inc.
- 12.2.8. Z-Medica LLC
- 12.2.9. Ethicon, Inc.
- 12.2.10. CR Bard, Inc.
- 12.2.11. Lifesciences Corporation
- 12.2.12. Baxter International, Inc.
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us